AbbVie’s Earnings Beat Wall Street’s Estimates. Investors Are Still Worried
AbbVie delivered a strong earnings beat this week, driven by its immunology portfolio. WSJ’s David Wainer explains why Wall Street is still jittery.
#wsj #thewallstreetjournal #pharma
The Wall Street Journal
The new WSJ Video takes you inside carefully selected stories and events in a visually captivating way so you can dig deeper into the news that matters to you. You’ll get breaking headlines, immersive features, interactive media and even virtual reality r...